Introduction: Andropause Is More Than a Hormone Number
Modern medicine has grown increasingly comfortable discussing menopause. Andropause, by contrast, still lives in the shadows—frequently dismissed as “just aging” or reduced to a laboratory value on a testosterone report. Yet the lived experience of andropause is not biochemical abstraction. It is fatigue, diminished confidence, reduced libido, impaired erections, irritability, and a quiet erosion of quality of life.
The pilot study conducted among Korean men over 35 years of age examined whether a daily 5 mg dose of tadalafil, administered for eight weeks, could improve overall quality of life (QoL) in men presenting with andropause symptoms, including erectile dysfunction (ED) . The results offer a clinically meaningful perspective: improvement in erectile function was accompanied by measurable gains in mental well-being, even in men whose total testosterone levels were within the normal range.
This distinction is important. Not all men with andropause symptoms have low testosterone. And not all men with normal testosterone feel well. The study challenges simplistic thinking and suggests that targeted pharmacologic intervention—specifically tadalafil 5 mg once daily—can improve both sexual function and psychological dimensions of health.
Study Design: An Open-Label Pilot with Focus on Quality of Life
The trial was a single-group, open-label, before-and-after study enrolling 40 Korean men aged over 35 years with andropause symptoms and ED . Participants received tadalafil 5 mg once daily for eight weeks.
Primary outcome: change in quality of life as measured by the Short Form-12 Health Survey (SF-12).
Secondary outcomes: changes in erectile function (IIEF-5), body composition (BIA), free radical levels, testosterone levels, and safety parameters.
Outcome measures were collected at baseline, 4 weeks, and 8 weeks. This design allowed time-dependent observation of both early and sustained effects.
Although lacking a placebo control—an acknowledged limitation—the structured measurements, predefined endpoints, and full participant completion (no dropouts) provide meaningful preliminary insight.
Who Were These Patients? A Real-World Andropause Profile
The average participant was 53.3 years old, predominantly married (97.5%), well-educated, and generally healthy . Importantly, 75% had normal total testosterone levels (≥3.5 ng/mL), while 25% had low levels.
On the ADAM questionnaire, a substantial proportion reported classic andropause features:
- 75% reported decreased libido
- 75% reported reduced strength or endurance
- 60% reported lack of energy
- 42.5% noted deterioration in work performance
- 27.5% reported decreased enjoyment of life
Only 12.5% explicitly reported reduced erection rigidity, yet all met criteria for ED based on IIEF-5 scoring. This discrepancy illustrates a key clinical truth: sexual dissatisfaction is not always described in anatomical terms. It often manifests as reduced confidence or diminished vitality.
These were not severely ill individuals. Their body mass index averaged 25.38 kg/m², and vital signs were within normal limits . In other words, this was a typical middle-aged population seen in outpatient practice.
Quality of Life: The Mental Domain Responds
The most compelling finding was the significant improvement in the Mental Component Score (MCS) of the SF-12 questionnaire.
At 4 weeks:
- MCS increased by 4.85 ± 8.15 points (P < .05)
At 8 weeks:
- MCS increased by 4.39 ± 8.48 points (P < .05)
Subdomains demonstrating significant improvement included:
- Mental health (MH)
- Role–emotional (RE)
- Vitality (at 8 weeks)
- General health perception (GH)
Interestingly, the Physical Component Score (PCS) did not show significant overall change. This is logical. Participants were screened to exclude major physical illness. The intervention was not aimed at musculoskeletal or cardiopulmonary limitations. Instead, it appears to have influenced psychological and emotional well-being.
This supports a clinically intuitive concept: erectile function is not merely mechanical. When erections improve, self-confidence improves. When confidence improves, mood improves. And when mood improves, overall quality of life rises.
The improvement in MCS, rather than PCS, suggests that tadalafil’s impact extends beyond penile hemodynamics into the realm of psychosocial health.
Erectile Function: A Predictable Yet Meaningful Gain
IIEF-5 scores improved significantly:
- +4.10 ± 5.52 points at 4 weeks
- +3.33 ± 4.77 points at 8 weeks (P < .001 overall)
Baseline mean IIEF-5 score was 12.20, consistent with moderate ED. By week 4, the mean rose to 16.30, and at week 8 it remained elevated at 15.53.
These gains are clinically relevant. A 4-point improvement on IIEF-5 often represents movement to a less severe ED category. For patients, this is not an abstract statistic—it may mean successful intercourse after months of frustration.
The study reinforces what is already known: tadalafil 5 mg once daily is effective for ED. However, the novelty here lies in demonstrating that such improvement correlates with measurable gains in quality of life in men with broader andropause symptoms.
Testosterone Levels: A Surprising Insight
Seventy-five percent of participants had normal total testosterone levels . Yet they reported classic andropause symptoms.
This finding is clinically important. It underscores that total testosterone alone does not fully capture androgenic function. Factors such as increased sex hormone-binding globulin (SHBG), receptor sensitivity changes, and tissue-level hormonal dynamics may influence symptomatology.
Guidelines recommend testosterone replacement therapy (TRT) when serum testosterone is <250 ng/dL and symptoms are present. However, many symptomatic men fall into the “normal but not optimal” category. For them, TRT may not be indicated or effective.
In this cohort, tadalafil improved quality of life regardless of testosterone status. This suggests that addressing erectile dysfunction directly can yield psychological and relational benefits independent of endocrine correction.
In practice, this expands therapeutic options. When TRT is not indicated, PDE5 inhibition may still offer meaningful benefit.
Oxidative Stress and Body Composition: No Significant Change
The study also evaluated bioelectrical impedance analysis (BIA) and free radical levels.
Results showed:
- No significant change in body composition variables
- No significant change in free radical levels
The baseline free radical level (mean 283 CARR U) was within cautionary oxidative stress range. Despite theoretical expectations that increased nitric oxide signaling might reduce oxidative stress, this was not observed.
The authors reasonably attribute this to multifactorial influences on oxidative balance—diet, smoking, physical activity, obesity, and environmental exposures. In a short 8-week window, expecting measurable shifts in systemic oxidative markers may be unrealistic.
These findings are neither disappointing nor surprising. Tadalafil is not an antioxidant supplement. Its benefit in this context appears primarily psychosexual rather than metabolic.
Safety and Tolerability: Reassuring Data
Safety outcomes were reassuring.
Adverse events were mild and infrequent:
- 5 mild cases at 4 weeks
- 2 mild cases at 8 weeks
- All judged “unlikely” or “not related” to tadalafil
Vital signs showed minimal changes, none clinically significant. Blood pressure decreased slightly but not meaningfully. Pulse rate rose marginally.
No participant discontinued therapy. Compliance was excellent, possibly reflecting once-daily dosing convenience and physician counseling.
These findings align with broader literature demonstrating that tadalafil 5 mg once daily is well tolerated in Korean and international populations.
Clinical Interpretation: What Does This Mean for Practice?
The study supports several practical conclusions.
First, andropause symptoms are multidimensional. Treating erectile dysfunction can positively influence emotional health, vitality, and perceived general health.
Second, tadalafil 5 mg once daily offers stable plasma levels, potentially supporting spontaneity and reducing performance anxiety compared to on-demand dosing.
Third, quality of life improvement appears independent of baseline testosterone levels. This broadens the population who may benefit from therapy.
Fourth, safety profile remains favorable over at least 8 weeks.
However, clinicians must remain cautious. The study was open-label and lacked a placebo control. Psychological expectancy effects may contribute to observed improvements. Larger randomized controlled trials are required.
Still, in everyday clinical practice, patient-reported improvement in mood and confidence is meaningful, even if partially placebo-mediated. Medicine is not only about molecules; it is about lived experience.
Conclusion: Restoring Confidence, Restoring Quality of Life
This pilot study demonstrates that tadalafil 5 mg once daily significantly improved erectile function and enhanced mental components of quality of life among Korean men with andropause symptoms over an 8-week period .
Physical health parameters remained stable. Body composition did not change. Oxidative stress markers were unaffected. But mental well-being improved—and that may be the most important outcome.
Erectile dysfunction is often the visible tip of the andropause iceberg. Beneath it lies fatigue, insecurity, strained relationships, and diminished vitality. By improving sexual function, tadalafil appears to exert a ripple effect across psychological domains.
For men whose testosterone levels are not frankly low, and for whom TRT is not indicated, tadalafil provides a viable alternative strategy to improve both sexual function and overall quality of life.
The message is straightforward: sometimes restoring function restores far more than function.
FAQ
1. Does tadalafil improve quality of life beyond erectile function?
Yes. In this study, tadalafil 5 mg once daily significantly improved the mental component of quality of life, including mental health, emotional role functioning, and vitality .
2. Is tadalafil effective in men with normal testosterone levels?
Yes. Seventy-five percent of participants had normal total testosterone levels, yet experienced significant improvement in erectile function and QoL with tadalafil .
3. Is daily tadalafil safe for men with andropause symptoms?
In this 8-week study, tadalafil 5 mg once daily was well tolerated, with only mild and infrequent adverse events and no significant changes in vital signs .
